Literature DB >> 22057405

Transcranial sonography in pantothenate kinase-associated neurodegeneration.

Vladimir S Kostić1, Marina Svetel, Milija Mijajlović, Aleksandra Pavlović, Milica Ječmenica-Lukić, Duško Kozić, Dušan Kozić.   

Abstract

After it was reported that increased tissue iron concentrations were associated with increased echogenicity of the substantia nigra (SN) obtained with transcranial sonography (TCS) in animal and postmortem studies, our goal was to use this method in a disorder characterized with iron accumulation in human brain tissue. Therefore, magnetic resonance imaging (MRI) and TCS were conducted in 5 unrelated patients with pantothenate kinase-associated neurodegeneration (PKAN), caused by PANK2 mutations. All patients had an eye of the tiger sign. Hypointense lesions on the T2-weighted MRI images were restricted to the globus pallidus (GP) and SN. TCS also revealed bilateral hyperechogenicity restricted to the LN and SN, with normal DTV values. Both TCS and MRI studies in PKAN patients are in accordance with the pathological findings that accumulation of iron, even in advanced cases, is restricted to the GP and SN, suggesting selective involvement of these structures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057405     DOI: 10.1007/s00415-011-6294-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Transcranial ultrasound in neurodegeneration with brain iron accumulation (NBIA).

Authors:  Jan Liman; Andreas Wellmer; Kevin Rostasy; Mathias Bähr; Pawel Kermer
Journal:  Eur J Paediatr Neurol       Date:  2011-08-03       Impact factor: 3.140

2.  Microglia activation is related to substantia nigra echogenicity.

Authors:  D Berg; J Godau; P Riederer; M Gerlach; T Arzberger
Journal:  J Neural Transm (Vienna)       Date:  2010-11-06       Impact factor: 3.575

3.  Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations.

Authors:  K D Sethi; R J Adams; D W Loring; T el Gammal
Journal:  Ann Neurol       Date:  1988-11       Impact factor: 10.422

Review 4.  Iron in the Hallervorden-Spatz syndrome.

Authors:  A H Koeppen; A C Dickson
Journal:  Pediatr Neurol       Date:  2001-08       Impact factor: 3.372

5.  Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings.

Authors:  D Berg; C Siefker; G Becker
Journal:  J Neurol       Date:  2001-08       Impact factor: 4.849

6.  In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.

Authors:  Luigi Zecca; Daniela Berg; Thomas Arzberger; Petra Ruprecht; Wolf D Rausch; Massimo Musicco; Davide Tampellini; Peter Riederer; Manfred Gerlach; Georg Becker
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

7.  Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.

Authors:  Norbert Brüggemann; Johann Hagenah; Kathrin Reetz; Alexander Schmidt; Meike Kasten; Inga Buchmann; Susanne Eckerle; Manfred Bähre; Alexander Münchau; Ana Djarmati; Joyce van der Vegt; Hartwig Siebner; Ferdinand Binkofski; Alfredo Ramirez; Maria I Behrens; Christine Klein
Journal:  Arch Neurol       Date:  2010-11

8.  T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.

Authors:  A McNeill; D Birchall; S J Hayflick; A Gregory; J F Schenk; E A Zimmerman; H Shang; H Miyajima; P F Chinnery
Journal:  Neurology       Date:  2008-04-29       Impact factor: 9.910

9.  Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.

Authors:  Daniela Berg; Wolfgang Roggendorf; Ute Schröder; Rüdiger Klein; Thomas Tatschner; Peter Benz; Oliver Tucha; Michael Preier; Klaus W Lange; Karlheinz Reiners; Manfred Gerlach; Georg Becker
Journal:  Arch Neurol       Date:  2002-06

10.  [Transcranial parenchymal sonography in the diagnosis of Parkinson's disease].

Authors:  Milija Mijajlović; Igor Petrović; Tanja Stojković; Marina Svetel; Elka Stefanova; Vladimir S Kostić
Journal:  Vojnosanit Pregl       Date:  2008-08       Impact factor: 0.168

View more
  7 in total

1.  Lenticular nucleus hyperechogenicity in Wilson's disease reflects local copper, but not iron accumulation.

Authors:  Uwe Walter; Marta Skowrońska; Tomasz Litwin; Grażyna Maria Szpak; Katarzyna Jabłonka-Salach; David Skoloudík; Ewa Bulska; Anna Członkowska
Journal:  J Neural Transm (Vienna)       Date:  2014-03-11       Impact factor: 3.575

2.  Pathophysiology and treatment of neurodegeneration with brain iron accumulation in the pediatric population.

Authors:  Susanne A Schneider; Giovanna Zorzi; Nardo Nardocci
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

Review 3.  Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  J Neural Transm (Vienna)       Date:  2012-12-02       Impact factor: 3.575

4.  7-Tesla Magnetic Resonance Imaging for Brain Iron Quantification in Homozygous and Heterozygous PANK2 Mutation Carriers.

Authors:  Petr Dusek; Elena Maria Tovar Martinez; Vince Istvan Madai; Robert Jech; Jan Sobesky; Friedemann Paul; Thoralf Niendorf; Jens Wuerfel; Susanne A Schneider
Journal:  Mov Disord Clin Pract       Date:  2014-10-23

5.  Transcranial Sonography in Mitochondrial Membrane Protein-Associated Neurodegeneration.

Authors:  Marta Skowronska; Tomasz Kmiec; Anna Czlonkowska; Iwona Kurkowska-Jastrzębska
Journal:  Clin Neuroradiol       Date:  2017-03-28       Impact factor: 3.649

6.  Transcranial sonography changes in heterozygotic carriers of the ATP7B gene.

Authors:  Marta Skowronska; Tomasz Litwin; Iwona Kurkowska-Jastrzębska; Anna Członkowska
Journal:  Neurol Sci       Date:  2020-04-09       Impact factor: 3.307

7.  Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA).

Authors:  Susanne A Schneider; Petr Dusek; John Hardy; Ana Westenberger; Joseph Jankovic; Kailash P Bhatia
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.